---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-002176"
form_type: "8-K"
ticker: "FNCHQ"
cik: "0001733257"
company_name: "Finch Therapeutics Group, Inc."
filed_at: "2021-10-19T23:59:59+00:00"
generated_at: "2026-06-28T20:02:04.874128+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Finch Therapeutics posts Jefferies IBD Summit slides; no new material disclosures

## Summary
- Furnished slides under Item 7.01 for Jefferies Virtual Next Generation IBD Therapeutics Summit held October 2021.
- Presentation titled 'Harnessing the Genomic Revolution & Machine Learning to Pioneer Microbiome Therapeutics'.
- No financial results, guidance, or pipeline updates provided in the filing.
- Slides available on company website under Events & Presentations.

## SEC filing metadata
- accession: 0000950170-21-002176
- form_type: 8-K
- ticker: FNCHQ
- cik: 0001733257
- company_name: Finch Therapeutics Group, Inc.
- filed_at: 2021-10-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733257/000095017021002176/0000950170-21-002176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733257/000095017021002176/fnch-20211019.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-002176
- JSON: https://secwatch.observer/filing/0000950170-21-002176.json
- Plain text: https://secwatch.observer/filing/0000950170-21-002176.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.